Replay available

Zimmer Biomet Holdings, Inc. (ZBH) Q4 2023 Earnings Call

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) Q4 2023 earnings conference call, held 2024-02-08. Replay captured from the company's public earnings webcast.

Thu, February 8, 2024 at 8:30 AMendedReplay
Zimmer Biomet Holdings, Inc. (ZBH) Q4 2023 Earnings Call

Investor webinar replay

Latest news releases

Companies on this event

Featured Presenters

Carrie Maddox

Chief Communications and Administration Officer

Yvonne Tornos

President and CEO

Suki Upadhyay

CFO and EVP, Finance, Operations, and Supply Chain

Larry Beagleson

Analyst at Wells Fargo

Matthew O'Brien

Analyst at Piper Sandler

Robbie Marcus

Analyst at JP Morgan

Joanne Wench

Analyst at Citi

Ryan Zimmerman

Analyst at BTIG

Travis Steed

Analyst at Bank of America

Jeff Johnson

Analyst at Baird

Jason Bedford

Analyst at Raymond James

Replay transcript excerpt

Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet fourth quarter 2023 earnings conference call. If anyone needs assistance at any time during the conference, please press the star followed by the zero. As a reminder, this conference is being recorded today, February 8th, 2024. Following today's presentation, there will be a question and answer session. At this time, all participants are in a listen-only mode. If you have a question, please press the star followed by the one on your push-button phone. I would now like to turn the conference over to Carrie Maddox, Chief Communications and Administration Officer. Please go ahead. Thank you, Operator, and good morning, everyone. Welcome to Zimmer Biomet's fourth quarter 2023 earnings conference call. Joining me today are Yvonne Tornos, our President and CEO, and CFO and EVP, Finance, Operations, and Supply Chain, Suki Upadhyay. Before we get started, I'd like to remind you that our comments during this call will include forward-looking statements. Actual results may differ materially from those indicated by the forward-looking statements due to a variety of risks and uncertainties. Please note, we assume no obligation to update these forward-looking statements, even if the actual results or future expectations change materially. Please refer to our SEC filings for a detailed discussion of these risks and uncertainties, in addition to the inherent limitations of such forward-looking statements. Additionally, the discussions on this call will include certain non-GAAP financial measures. some of which are forward-looking non-GAAP financial measures. Reconciliation of these measures to the most directly comparable GAAP financial measures and an explanation of our basis for calculating these measures is inc...

More from Zimmer Biomet Holdings, Inc.